Immunohistochemical Expression of E-Cadherin and β-Catenin in Feline Mammary Tumours

Journal of Comparative Pathology

Volumn 147, Issue 2-3, 2012, Pages 161-170

  Zappulli, V ^a   De Cecco, S ^a   Trez, D ^a   Caliari, D ^a   Aresu, L ^a   Castagnaro, M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

catenin; Cat; E cadherin; Mammary tumour

Indexed keywords

BETA CATENIN; UVOMORULIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; BREAST DYSPLASIA; BREAST HYPERPLASIA; BREAST METASTASIS; CAT DISEASE; CELL INVASION; CELLULAR DISTRIBUTION; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYSTEMATIC REVIEW; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CADHERINS; CARCINOMA, DUCTAL, BREAST; CAT DISEASES; CATS; CELL NUCLEUS; FEMALE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MAMMARY NEOPLASMS, ANIMAL; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

FELIDAE;

EID: 84864413860     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2012.02.004     Document Type: Article

References (52)

1. Aresu L., Pregel P., Zanetti R., Caliari D., Biolatti B., et al. E-cadherin and β-catenin expression in canine colorectal adenocarcinoma. Research in Veterinary Science 2010, 89:409-414.
2. Asgeirsson K.S., Jónasson J.G., Tryggvadóttir L., Olafsdóttir K., Sigurgeirsdóttir J.R., et al. Altered expression of E-cadherin in breast cancer. Patterns, mechanisms and clinical significance. European Journal of Cancer 2000, 36:1098-1106.
3. Blick T., Hugo H., Widodo E., Waltham M., Pinto C., et al. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. Journal of Mammary Gland Biology and Neoplasia 2010, 15:235-252.
4. Bremnes R.M., Veve R., Hirsch F.R., Franklin W.A. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002, 36:115-124.
5. Brunetti B., Sarli G., Preziosi R., Leprotti S., Benazzi C. E-cadherin expression in canine mammary carcinomas with regional lymph node metastases. Journal of Veterinary Medicine A: Physiology, Pathology and Clinical Medicine 2003, 50:496-500.
6. Brunetti B., Sarli G., Preziosi R., Monari I., Benazzi C. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumours. Veterinary Pathology 2005, 42:781-787.
7. Burkholm I.K., Nesland J.M., Karesen R., Jacobsen U., Borresen-Dale A.L. E-cadherin and a-, b-, and g-catenin protein expression in relation to metastasis in human breast carcinoma. Journal of Pathology 1998, 185:262-266.
8. Chan A.O. E-cadherin in gastric cancer. World Journal of Gastroenterology 2006, 12:199-203.
9. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
10. De Matos A.J., Lopes C.C., Faustino A.M., Carvalheira J.G., Dos Santos M.S., et al. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours. Acta Pathologica Microbiologica et Immunologica Scandinavica 2007, 115:327-334.
11. Debruyne P., Vermeulen S., Mareel M. The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterologica Belgica 1999, 62:393-402.
12. Dias Pereira P., Gärtner F. Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue. Veterinary Record 2003, 153:297-302.
13. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology 1991, 19:403-410.
14. Gama A., Paredes J., Gärtner F., Alves A., Schmitt F. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Veterinary Journal 2008, 177:45-53.
15. Gil da Costa R.M., Rema A., Pires M.A., Gärtner F. Two canine Merkel cell tumours: immunoexpression of c-KIT, E-cadherin, beta-catenin and S100 protein. Veterinary Dermatology 2010, 21:198-201.
16. Gil da Costa R.M., Santos M., Amorim I., Lopes C., Pereira P.D., et al. An immunohistochemical study of feline endometrial adenocarcinoma. Journal of Comparative Pathology 2009, 140:254-259.
17. Giroldi L.A., Shimazui T., Schalken J.A., Yamasaki H., Bringuier P.P. Classical cadherins in urological cancers. Morphologie 2000, 84:31-38.
18. Goldschmidt M., Peña L., Rasotto R., Zappulli V. Classification and grading of canine mammary tumors. Veterinary Pathology 2011, 48:117-131.
19. Han J.I., Kim D.Y., Na K.J. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumour. Veterinary Pathology 2010, 47:285-291.
20. Hechtman J.F., Raoufi M., Fiel M.I., Taouli B., Facciuto M., et al. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. American Journal of Surgical Pathology 2011, 35:927-932.
21. Hirohashi S., Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Science 2003, 94:575-581.
22. Ismael O., Shimada A., Hama A., Takahashi Y., Sato Y., et al. Congenital pancreatoblastoma associated with β-catenin mutation. Pediatric Blood and Cancer 2012, 58:827.
23. Jiang W.G. E-cadherin and its associated protein catenins, cancer invasion and metastasis. British Journal of Surgery 1996, 83:437-446.
24. Kawahara A., Harada H., Abe H., Yamaguchi T., Taira T., et al. Nuclear β-catenin expression in basal cell adenomas of salivary gland. Journal of Oral Pathology and Medicine 2011, 40:460-466.
25. Khramtsov A.I., Khramtsova G.F., Tretiakova M., Huo D., Olopade O.I., et al. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. American Journal of Pathology 2010, 176:2911-2920.
26. Klemm F., Bleckmann A., Siam L., Chuang H.N., Rietkötter E., et al. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis 2011, 32:434-442.
27. Li Y., Tang Y., Zhou R., Sun D., Duan Y., et al. Genetic polymorphism in the 3'-untranslated region of the E-cadherin gene is associated with risk of different cancers. Molecular Carcinogenesis 2011, 50:57-62.
28. Mareel M., Berx G., Van Roy F., Bracke M. Cadherin/catenin complex: a target for anti-invasive therapy?. Journal of Cellular Biochemistry 1996, 61:524-530.
29. Matos A.J., Lopes C., Carvalheira J., Santos M., Rutteman G.R., et al. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables. Journal of Comparative Pathology 2006, 134:182-189.
30. Meniel V., Clarke A.R. Wnt-Cadherin connections in normal and neoplastic mammary epithelium. Journal of Mammary Gland Biology and Neoplasia 2003, 8:435-447.
31. Misdorp W., Else R.W., Hellmèn E., Lipscomb T.P. Histological Classification of Mammary Tumours of the Dog and Cat. WHO International Histological Classification of Tumours of Domestic Animals 2001, Vol. 7. Armed Forces Institute of Pathology, American Registry of Pathology, Washington DC.
32. Nault J.C., Zucman-Rossi J. Genetics of hepatobiliary carcinogenesis. Seminars in Liver Disease 2011, 31:173-187.
33. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
34. Nowak M., Madej J.A., Dziegiel P. Expression of E-cadherin, β-catenin and Ki-67 antigen and their reciprocal relationships in mammary adenocarcinomas in bitches. Folia Histochemica et Cytobiologica 2007, 45:233-238.
35. Nowak M., Madej J.A., Podhorska-Okolow M., Dziegiel P. Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas. In Vivo 2008, 22:463-469.
36. Reis A.L., Carvalheira J., Schmitt F.C., Gärtner F. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours. Veterinary Record 2003, 152:621-624.
37. Remmele W., Stegner H.E. Vorschlag zur einheitlichen definition eines immunoreaktiven score fur den immunohistochemichen ostrogerezeptor-nachweis (ER-ICA) im mamakarzinomgewebe. Pathologe 1987, 8:138-140.
38. Restucci B., Maiolino P., Martano M., Esposito G., De Filippis D., et al. Expression of beta-catenin, E-cadherin and APC in canine mammary tumours. Anticancer Research 2007, 27:3083-3089.
39. Rodo A., Malicka E. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches. Polish Journal of Veterinary Science 2008, 11:47-54.
40. Russell R.C., Ohh M. The role of VHL in the regulation of E-cadherin: a new connection in an old pathway. Cell Cycle 2007, 6:56-59.
41. Sarli G., Preziosi R., De Tolla L., Brunetti B., Benazzi C. E-cadherin immunoreactivity in canine mammary tumours. Journal of Veterinary Diagnostic Investigation 2004, 16:542-547.
42. Siitonen S.M., Kononen J.T., Helin H.J., Rantala I.S., Holli K.A., et al. Reduced E-caderin expression is associated with invasiveness and unfavorable prognosis in breast cancer. American Journal of Clinical Pathology 1996, 105:349-402.
43. Stein T.J., Holmes K.E., Muthuswamy A., Thompson V., Huelsmeyer M.K. Characterization of β-catenin expression in canine osteosarcoma. Veterinary and Comparative Oncology 2011, 9:65-73.
44. Takauji S., Watanabe M., Uyama R., Nakagawa T., Miyajima N., et al. Expression and subcellular localization of e-cadherin, α-catenin, and β-catenin in 8 feline mammary tumour cell lines. Journal of Veterinary Medical Science 2007, 69:831-834.
45. Tang D., Xu S., Zhang Q., Zhao W. The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer. Medical Oncology 2011, (Epub ahead of print).
46. Teulière J., Faraldo M.M., Shtutman M., Birchmeier W., Huelsken J., et al. Beta-catenin-dependent and -independent effects of delta N-plakoglobin on epidermal growth and differentiation. Molecular and Cellular Biology 2004, 24:8649-8661.
47. Torres L.N., Matera J.M., Vasconcellos C.H., Avanzo J.L., Hernandez-Blazquez F.J., et al. Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands. Veterinary Pathology 2005, 42:633-641.
48. Udhayakumar G., Jayanthi V., Devaraj N., Devaraj H. Nuclear translocation of β-catenin correlates with CD44 upregulation in Helicobacter pylori-infected gastric carcinoma. Molecular and Cellular Biochemistry 2011, 357:283-293.
49. Van Aken E., De Wever O., Correia da Rocha A.S., Mareel M. Defective E-cadherin/catenin complexes in human cancer. Virchow's Archive 2001, 439:725-751.
50. Wijnhoven B.P., Dinjens W.N., Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. British Journal of Surgery 2000, 87:992-1005.
51. Zappulli V, Caliari D, Rasotto R, Castagnaro M (2008) Immunomarker espression in feline mammary tumours. In: Proceedings of the 25th Meeting of the European Society of Veterinary Pathology, Dubrovnik (Croatia), p. 261.
52. Zappulli V., De Zan G., Cardazzo B., Bargelloni L., Castagnaro M. Feline mammary tumours in comparative oncology. Journal of Dairy Research 2005, 72:98-106.